Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Can J Vet Res ; 77(2): 142-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-24082407

ABSTRACT

Abundant lymphocyte infiltration is frequently found in canine malignant mammary tumors, but the pathological features and immunophenotypes associated with the infiltration remain to be elucidated. The aim of the present study was to evaluate the relationship between lymphocyte infiltration, histopathological features, and molecular phenotype in canine mammary carcinoma (MC). The study was done with archived formalin-fixed, paraffin-embedded samples (n = 47) by histologic and immunohistochemical methods. The degree of lymphocyte infiltration was evaluated by morphologic analysis, and the T- and B-cell populations as well as the T/B-cell ratio were evaluated by morphometric analysis; results were compared with the histologic features and molecular phenotypes. The degree of lymphocyte infiltration was significantly higher in MCs with lymphatic invasion than in those without lymphatic invasion (P < 0.0001) and in tumors of high histologic grade compared with those of lower histologic grade (P = 0.045). Morphometric analysis showed a larger amount of T-cells and B-cells in MCs with a higher histologic grade and lymphatic invasion, but the T/B ratio did not change. Lymphocyte infiltration was not associated with histologic type or molecular phenotype, as assessed from the immunohistochemical expression of epidermal growth factor receptor 2, estrogen receptor, cytokeratin 14, and p63. Since intense lymphocyte infiltration was associated with aggressive histologic features, lymphocytes may be important for tumor aggressiveness and greater malignant behavior in the tumor microenvironment.


Une infiltration lymphocytaire abondante est fréquemment retrouvée dans les tumeurs mammaires malignes chez le chien, mais les caractéristiques pathologiques et les immunophénotypes associés avec l'infiltration restent à être élucidés. L'objectif de la présente étude était d'évaluer la relation entre l'infiltration lymphocytaire, les caractéristiques histopathologiques, et le phénotype moléculaire dans les carcinomes mammaires canins (CM). Cette étude a été réalisée en utilisant des méthodes histologiques et immunohistochimiques sur des échantillons archivés fixés à la formaline et enrobés de paraffine (n = 47). Le degré d'infiltration lymphocytaire a été évalué par analyse morphologique, et les populations de lymphocytes T et B ainsi que le ratio de cellules T/B ont été évalués par analyses morphométriques; les résultats ont été comparés avec les caractéristiques histologiques et les phénotypes moléculaires. Le degré d'infiltration lymphocytaire était significativement plus élevé dans les CM avec invasion lymphatique que dans ceux sans invasion lymphatique (P < 0,001) et dans les tumeurs de grade histologique élevé comparativement à ceux avec un grade histologique faible (P = 0,045). Les analyses morphométriques ont montré une quantité plus grande de cellules T et B dans les CM ayant un grade histologique élevé et invasion lymphatique, mais le ratio T/B n'a pas changé. L'infiltration lymphocytaire n'était pas associée avec le type histologique ou le phénotype moléculaire, tel qu'évalué par l'expression immunohistochimique du récepteur 2 du facteur de croissance épidermique, du récepteur d'estrogène, de cytokératine 14, et de p63. Étant donné que l'infiltration lymphocytaire marquée était associée avec des caractéristiques histologiques d'agressivité, les lymphocytes pourraient être importants pour l'agressivité des tumeurs et le comportement de malignité plus important dans le microenvironnement de la tumeur.(Traduit par Docteur Serge Messier).


Subject(s)
Dog Diseases/pathology , Immunohistochemistry/veterinary , Lymphocytes, Tumor-Infiltrating/pathology , Mammary Neoplasms, Animal/pathology , Animals , Dogs , Female , Gene Expression Regulation, Neoplastic/physiology , Immunophenotyping , Lymphocytes, Tumor-Infiltrating/metabolism , Phenotype
2.
J Vet Med Sci ; 75(2): 237-40, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23047431

ABSTRACT

We report here the clinical presentation and successful surgical management of synovial hemangioma accompanied by cruciate ligament injury in a dog. Surgical correction of cruciate ligament injury was performed after removing torn cruciate ligaments, synovial mass and masses attached to the ligaments and distal femoral articular cartilage. At 10 months, the dog has showed no evidence of recurrence in the stifle joint. Synovial hemangioma, although a seemingly rare cause of stifle joint pathology, should be considered in the differential diagnosis for cruciate ligament injury when a circumscribed intra-articular soft tissue mass is evident radiographically with cranial or caudal drawer motion. This is the first case report in a dog to describe synovial hemangioma accompanied by cruciate ligament injury.


Subject(s)
Anterior Cruciate Ligament Injuries , Dog Diseases/pathology , Hemangioma/veterinary , Joint Diseases/veterinary , Synovial Membrane/pathology , Animals , Dog Diseases/etiology , Dogs , Female , Hemangioma/pathology , Hemangioma/surgery , Joint Diseases/pathology , Joint Diseases/surgery , Stifle/pathology , Stifle/surgery
3.
Vet J ; 195(3): 366-72, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22901454

ABSTRACT

BRCA1 is a high-penetrance breast cancer susceptibility gene and BRCA1-associated breast cancer has a high familial prevalence that is more common among certain populations of humans. A similar high prevalence also exists for canine mammary tumors (CMTs) and the objective of this study was to determine the breed-related differences in malignant CMTs. Comparative analyses of the expression of various prognostic factors for CMTs, including BRCA1, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) were conducted on 139 malignant CMT cases from five breeds with the highest prevalence of CMTs in Korea. Significant breed-related differences were observed in the expression of BRCA1 (P=0.003), histological grade (P=0.038), and extensive lymphatic invasion (P=0.042). The Shih Tzu breed had the highest proportion of dogs with malignant CMT and strong overexpression of BRCA1. Cytoplasmic and membranous expression of BRCA1 was associated with the ER negative (P=0.004), PR negative (P=0.046), and triple negative (ER, PR, and HER-2 negative; P=0.016) phenotype and the basal-like molecular subtype (P=0.019) in Shih Tzu dogs. Since these features are similar to BRCA1-related human breast cancer, dogs with BRCA1-associated CMT, particularly Shih Tzu dogs, may serve as a suitable spontaneous model, although additional molecular studies are needed.


Subject(s)
BRCA1 Protein/metabolism , Dog Diseases/metabolism , Gene Expression Regulation, Neoplastic/physiology , Mammary Neoplasms, Animal/metabolism , Animals , BRCA1 Protein/genetics , Dog Diseases/classification , Dog Diseases/epidemiology , Dogs , Female , Genes, erbB-2/physiology , Mammary Neoplasms, Animal/classification , Mammary Neoplasms, Animal/epidemiology , Mammary Neoplasms, Animal/genetics , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Receptors, Progesterone/genetics , Receptors, Progesterone/metabolism , Republic of Korea/epidemiology
4.
Int J Oncol ; 42(1): 317-26, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23174888

ABSTRACT

Ginseng has been used for cancer prevention. However, little is known about its active components and the molecular mechanisms underlying its effects. Recently, we isolated a unique lysophosphatidic acid (LPA) receptor ligand, gintonin. Gintonin contains approximately 9.5% LPA, mainly LPA C18:2. Autotaxin (ATX) is responsible for metastasis by overproducing LPA in cancers. However, LPA, particularly LPA C18:2, is a strong negative feedback ATX inhibitor. It is unknown whether gintonin inhibits ATX activity and whether gintonin­induced ATX inhibition is coupled with antimetastatic activity. In this study, we examined whether gintonin and LPA C18:2 inhibit ATX activity and metastasis­related cellular activities in melanoma cells. We found that gintonin and LPA C18:2 inhibited the purified and secreted ATX activity from melanoma cells in a concentration­dependent manner. Gintonin also inhibited cell migration with a minimal inhibition of cell growth. The oral administration of gintonin or LPA C18:2 inhibited lung metastasis induced by tail­vein inoculations of melanoma cells. Moreover, the oral administration of gintonin significantly suppressed the tumor growth induced by subcutaneous grafts of melanoma cells. A histological analysis showed that the oral administration of gintonin reduced tumor necrosis, the pleomorphism of tumor cells, tumor cell mitosis and angiogenesis. The present study demonstrates that the gintonin­induced inhibition of ATX activity may be the molecular basis of ginseng­induced antimetastatic and antitumor activities.


Subject(s)
Lung Neoplasms/prevention & control , Melanoma, Experimental/prevention & control , Panax/chemistry , Phosphoric Diester Hydrolases/chemistry , Phytotherapy , Plant Extracts/pharmacology , Animals , Apoptosis/drug effects , Blotting, Western , Cell Movement/drug effects , Cell Proliferation/drug effects , Immunoenzyme Techniques , Lung Neoplasms/metabolism , Lung Neoplasms/secondary , Male , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Phosphoric Diester Hydrolases/metabolism , Tumor Cells, Cultured
5.
Can Vet J ; 53(5): 559-64, 2012 May.
Article in English | MEDLINE | ID: mdl-23115372

ABSTRACT

This report describes a primary central nervous system B-cell lymphoma in a 3-year-old intact female Maltese dog. Canine primary central nervous system lymphomas constitute about 4% of all intracranial primary neoplasms, but comprehensive histopathologic classifications have rarely been carried out. This is the first report of this disease in a young adult dog.


Subject(s)
Central Nervous System Neoplasms/veterinary , Dog Diseases/diagnosis , Lymphoma, B-Cell/veterinary , Age Factors , Animals , Central Nervous System Neoplasms/diagnosis , Central Nervous System Neoplasms/pathology , Dog Diseases/pathology , Dogs , Fatal Outcome , Female , Lymphoma, B-Cell/diagnosis , Lymphoma, B-Cell/pathology
6.
Can J Vet Res ; 76(1): 62-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22754097

ABSTRACT

This retrospective study was done to characterize the levels of vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1 (HIF-1α) in dog brains with neo-vascularization in the cerebral cortex of frontal, temporal, and parietal lobe by using immunohistochemistry (IHC) and Western blot. In neo-vascularized (NV) brains, we analyzed the number and area of blood vessels and the expression of VEGF and HIF-1α. The IHC results showed that the number and area of blood vessels, as assessed by immunolabeling for von Willebrand factor, was higher in the NV brain than in the control brain. The Western blot results showed that the level of VEGF was increased, predominantly in NV brain of the cerebral cortex relative to the clinically normal cerebral cortex, whereas the expression of HIF-1α in NV brains was not different from the control brains. Our study showed that dilatation of vessels and development of new vessels in the cerebral cortex were observed in cases of canine CNS disease and found increased expression of VEGF in canine brains with neo-vascularization.


Subject(s)
Brain/blood supply , Brain/metabolism , Central Nervous System Diseases/veterinary , Dog Diseases/metabolism , Vascular Endothelial Growth Factor A/metabolism , Animals , Blotting, Western/veterinary , Central Nervous System Diseases/metabolism , Dogs , Female , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Immunohistochemistry/veterinary , Male , Neovascularization, Pathologic/metabolism , Retrospective Studies
7.
J Vet Diagn Invest ; 23(5): 1079-82, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21908380

ABSTRACT

Inflammatory mammary carcinoma (IMC) is a specific type of rare, very aggressive, and highly metastatic mammary cancer in both human beings and dogs. A 10-year-old female spayed Shih Tzu dog was diagnosed with secondary IMC. At necropsy, brain metastasis of mammary neoplastic cells was observed in tissues of the cerebrum and cerebellum. Metastases were also found in other distant organs such as heart, lung, liver, spleen, and inguinal lymph node. There is limited data about the metastasis of IMC and its pattern. The current report of IMC with brain metastases contributes to the understanding of metastatic IMC.


Subject(s)
Brain Neoplasms/veterinary , Carcinoma/veterinary , Inflammation/veterinary , Mammary Neoplasms, Animal/pathology , Animals , Brain Neoplasms/secondary , Carcinoma/pathology , Dog Diseases , Dogs , Fatal Outcome , Female , Inflammation/pathology
8.
J Vet Sci ; 12(3): 299-301, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21897106

ABSTRACT

We analyzed the expression level and cellular localization of pro- and anti-inflammatory cytokines and histopathologically characterized canine traumatic brain injury (TBI). Canine TBI brains revealed subarachnoid and cerebral cortical hemorrhage, neutrophilic infiltration, neuronal necrosis, astrocytosis, and vasogenic edema. Immunohistochemical evaluations suggested that both pro-inflammatory cytokines [interleukin (IL)-1ß, IL-6, and tumor necrosis factor-α] and anti-inflammatory cytokines [IL-10 and transforming growth factor-beta (TGF-ß)] were highly expressed in neurons and neutrophils. In particular, the highest magnitude of expression was identified for IL-1ß and TGF-ß. This data helps describe the pathologic characteristics of canine TBI, and may help in the design of potential therapeutic approaches to control secondary damage by inflammatory cytokines.


Subject(s)
Brain Injuries/pathology , Brain Injuries/veterinary , Brain/immunology , Brain/pathology , Animals , Brain Injuries/immunology , Dogs , Humans , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukin-1beta/immunology , Interleukin-1beta/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta/metabolism , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
9.
J Vet Sci ; 11(4): 277-83, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21113095

ABSTRACT

Renal disease includes conditions affecting the glomeruli, tubules, interstitium, pelvis, and vasculature. Diseases of the kidney include glomerular diseases, diseases of the tubules and interstitium, diseases of renal pelvis, and developmental abnormalities. Renal tissue samples (n = 70) submitted to the Department of Veterinary Pathology of Konkuk University from 2003 to 2008 were included in this study. Tissue histopathology was performed using light microscopy with hematoxylin and eosin stains. Masson's trichrome, Congo Red, and Warthin starry silver staining were applied in several individual cases. Glomerular diseases (22.9%), tubulointerstitial diseases (8.6%), neoplastic diseases (8.6%), conditions secondary to urinary obstruction (24.3%), and other diseases (35.7%) were identified. Glomerulonephritis (GN) cases were classified as acute proliferative GN (5.7%), membranous GN (4.3%), membranoproliferative GN (4.3%), focal segmental GN (2.9%), and other GN (4.2%). The proportion of canine GN cases presently identified was not as high as the proportions identified in human studies. Conversely, urinary obstruction and end-stage renal disease cases were relatively higher in dogs than in human populations.


Subject(s)
Dog Diseases/pathology , Kidney Diseases/veterinary , Kidney/pathology , Animals , Dogs , Female , Humans , Kidney Diseases/pathology , Male , Republic of Korea , Retrospective Studies
10.
BMC Cancer ; 10: 243, 2010 May 28.
Article in English | MEDLINE | ID: mdl-20509912

ABSTRACT

BACKGROUND: Human seminoma is classified as classical seminoma (SE) and spermatocytic seminoma (SS). Human SE is known to be more malignant and metastasizing more frequently than SS. Tumor angiogenesis is highly related with tumor progression and metastasis, with microvessel density (MVD) being an important parameter of metastatic potential. Canine seminoma is not yet well-established as SE or SS type including correlation with angiogenesis. We classified canine SE and SS, and then compared them to tumor associated vessels. METHODS: Twenty-three cases of canine seminomas (2 intratubular, 9 diffuse, and 12 intratubular/diffuse seminomas showing both intratubular and diffuse patterns) were classified as SE or SS by immunohistochemistry (IHC) using monoclonal antibody against PLAP and by PAS stain. The histopathological data were then compared to see if there was a correlation with SE or SS. Angiogenesis of seminomas were evaluated by immunohistochemical assay using polyclonal antibody against Von Willebrand factor (vWF) and by calculating the means of MVD, vessels area and perimeters using computerized image analysis. Statistical Package for Social Sciences (SPSS) program was used for various statistical analyses. RESULTS: The numbers of PLAP+/PAS+ canine SEs were 8/23 (34.8%) and PLAP-/PAS- SSs were 15/23 (61.2%). All SE cases (8/8, 100%) were intratubular/diffuse types. SS types included 2 intratubular (2/15, 13.3%), 9 diffuse (9/15, 60%), and 4 intratubular/diffuse (4/15, 26.7%) types. MVD and vascular parameters in SEs were significantly higher than in SSs, showing the highest value in the intratubular/diffuse type. Seminomas observed with neoplastic cells invasion of vessels presented higher perimeter and area values than seminomas without conformed neoplastic cells invasion. CONCLUSION: In this study, we demonstrated a positive relationship between canine SE and tumor angiogenesis. Furthermore, we also showed that a tumor cells invasion of vessels were a correlated vascular parameter. Although metastasis of canine seminomas has rarely been reported, our results support that canine SE could have high metastatic potential similar to the human counterpart. Further studies are required to clarify the relationship between canine SE and clinical data with metastatic factors.


Subject(s)
Dog Diseases/pathology , Neovascularization, Pathologic/veterinary , Seminoma/veterinary , Testicular Neoplasms/veterinary , Alkaline Phosphatase/analysis , Animals , Biomarkers, Tumor/analysis , Dog Diseases/classification , Dog Diseases/metabolism , Dogs , GPI-Linked Proteins , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Isoenzymes/analysis , Male , Microvessels/pathology , Neoplasm Invasiveness , Neovascularization, Pathologic/classification , Neovascularization, Pathologic/metabolism , Prostate-Specific Antigen/analysis , Seminoma/blood supply , Seminoma/chemistry , Seminoma/classification , Seminoma/secondary , Staining and Labeling , Terminology as Topic , Testicular Neoplasms/blood supply , Testicular Neoplasms/chemistry , Testicular Neoplasms/classification , Testicular Neoplasms/pathology , von Willebrand Factor/analysis
11.
J Vet Sci ; 11(1): 21-5, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20195061

ABSTRACT

In August 2008, forty dogs out of 400 developed oral warts in a breeding farm in Korea. Canine oral papilloma infection is a common disease in dogs. However, there has been no report of an outbreak of canine oral papillomavirus (COPV) in a group of dogs or in dog breeding farms in Korea, and the genetic analysis of COPV in Korea has yet to be performed. This study diagnosed canine oral papilloma from the oral samples of these dogs based on histopathological examination and immunohistochemistry. Polymerase chain reaction was applied to amplify the corresponding products using preexisting primer sets for COPV and a universal human papillomavirus targeting L1 gene. Further genetic analysis of the major viral capsid gene L1 confirms the sequences of Korean COPV, which shows a close relationship to previously reported COPV. This study describes the histopathological and immunohistochemical characteristics of canine oral papilloma in a group of breeding dogs in Korea and discloses the complete L1 gene sequences of Korean COPV.


Subject(s)
Disease Outbreaks/veterinary , Dog Diseases/virology , Lambdapapillomavirus/isolation & purification , Mouth Diseases/veterinary , Papillomavirus Infections/veterinary , Animals , Base Sequence , Capsid Proteins/chemistry , Capsid Proteins/genetics , DNA, Viral/chemistry , DNA, Viral/genetics , Dog Diseases/epidemiology , Dogs , Immunohistochemistry/veterinary , Korea/epidemiology , Lambdapapillomavirus/genetics , Molecular Sequence Data , Mouth Diseases/epidemiology , Mouth Diseases/virology , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA
12.
J Vet Sci ; 10(1): 1-7, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19255517

ABSTRACT

Primary testicular tumors are the most common causes of cancer in male dogs. Overall, the majority of canine patients should be cured by testicular surgery. However, tumor markers are not well-known in veterinary medicine. We sought to determine using immunohistochemistry whether the combined human testicular tumor markers (placental alkaline phosphatase, OCT3/4, CD30, alpha-fetoprotein, inhibin-alpha, vimentin, c-KIT, and desmin) are expressed in canine seminomas and Sertoli cell tumors (SCTs). We examined 35 canine testicular tumors, 20 seminomas and 15 SCTs. c-KIT was expressed markedly in canine seminomas. Both inhibin-alpha and vimentin were expressed significantly in canine SCTs. The results of this study demonstrate differences and similarities between tumor marker expression of testicular tumors in dogs and humans. All the main markers in current routine use are discussed as well as potential useful markers for benign and malignant tumors, and tumor progression.


Subject(s)
Dog Diseases/pathology , Immunohistochemistry/veterinary , Seminoma/veterinary , Sertoli Cell Tumor/veterinary , Animals , Biomarkers, Tumor/metabolism , Dogs , Male , Seminoma/metabolism , Seminoma/pathology , Sertoli Cell Tumor/metabolism , Sertoli Cell Tumor/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...